October 16


11- Future of Cancer Epigenetic Drugs – Interview with Dr. Bill Nelson

By heheals

October 16, 2020

For additional information, visit http://www.cancerquest.org/bill-nelson-interview

Dr. Nelson from Johns Hopkins directs his research on epigenetic changes in prostate cancer. Epigenetics deals with changes that affect the activity of a gene without changing the DNA sequence of the gene. The changes include DNA methylation and histone acetylation. Dr. Nelson also investigates how these changes can be targeted by cancer drugs.

Dr. Bill Nelson describes his thoughts about the future advances for cancer.

To learn more about cancer and watch additional interviews, please visit the CancerQuest website at http://www.cancerquest.org



About the author

Leave a Repl​​​​​y

Your email address will not be published. Required fields are marked

{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}

Never miss a good story!

 Subscribe to our newsletter to keep up with the latest trends!